Apimeds Pharmaceuticals US Inc
APUS
View Detailed Chart
1.540USD
-0.230-12.99%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
19.37MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-12.99%
5 Days
-28.04%
1 Month
-35.83%
6 Months
-5.52%
Year to Date
0.00%
1 Year
0.00%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Apimeds Pharmaceuticals US Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Apimeds Pharmaceuticals US Inc Info
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Ticker SymbolAPUS
CompanyApimeds Pharmaceuticals US Inc
CEOMenon (Vin)
Websitehttps://www.apimedsus.com/
FAQs
What is the current price of Apimeds Pharmaceuticals US Inc (APUS)?
The current price of Apimeds Pharmaceuticals US Inc (APUS) is 1.540.
What is the symbol of Apimeds Pharmaceuticals US Inc?
The ticker symbol of Apimeds Pharmaceuticals US Inc is APUS.
What is the 52-week high of Apimeds Pharmaceuticals US Inc?
The 52-week high of Apimeds Pharmaceuticals US Inc is 4.000.
What is the 52-week low of Apimeds Pharmaceuticals US Inc?
The 52-week low of Apimeds Pharmaceuticals US Inc is 1.370.
What is the market capitalization of Apimeds Pharmaceuticals US Inc?
The market capitalization of Apimeds Pharmaceuticals US Inc is 19.37M.
What is the net income of Apimeds Pharmaceuticals US Inc?
The net income of Apimeds Pharmaceuticals US Inc is -1.39M.
Is Apimeds Pharmaceuticals US Inc (APUS) currently rated as Buy, Hold, or Sell?
According to analysts, Apimeds Pharmaceuticals US Inc (APUS) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Apimeds Pharmaceuticals US Inc (APUS)?
The Earnings Per Share (EPS TTM) of Apimeds Pharmaceuticals US Inc (APUS) is -0.497.
Related Instruments
+1.32%
-0.88%
+1.75%
+0.83%
+0.60%
+0.38%
+0.91%
+1.03%
+2.32%
+0.60%
+0.40%
+1.97%
+1.63%
+1.21%
+0.65%
+0.66%
+2.57%
0.00%
-0.44%
+1.06%
